Revolutionizing genetic disease treatment: The case of exagamglogene autotemcel

被引：0
|
作者：
Rao, Shuquan [1 ]
Yao, Yao [1 ]
Huo, Wenxuan [2 ,3 ]
Cao, Yang [4 ,5 ]
Budde, Lihua E. [6 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[2] Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Natl Clin Res Ctr Hematol Dis, Beijing 100044, Peoples R China
[3] Chinese Acad Med Sci 2019RU029, Key Tech Diag & Treatments Hematol Malignancies, Res Unit, Beijing 100044, Peoples R China
[4] Huazhong Univ Sci & Technol, Dept Hematol, Wuhan 430030, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Canc Biol Res Ctr, Wuhan 430030, Peoples R China
[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Stem Cell Transplantat, Duarte, CA 91010 USA
来源：
INNOVATION | 2024年 / 5卷 / 03期
关键词：
D O I：
10.1016/j.xinn.2024.100619
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] MODEL-PROJECTED CLINICAL OUTCOMES OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) IN PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN CANADA
    Udeze, C.
    Gargano, M.
    Kaindl, L.
    Kane, S.
    Zhou, A.
    Jain, S.
    Lopez, A.
    VALUE IN HEALTH, 2024, 27 (12) : S130 - S130
  • [32] MODEL-PROJECTED LONG-TERM CLINICAL OUTCOMES OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) GENEEDITED THERAPY IN PATIENTS WITH TRANSFUSIONDEPENDENT BETA-THALASSEMIA IN THE UNITED KINGDOM
    Udeze, C.
    Jeyakumar, S.
    Fang, H.
    Yang, H.
    Li, N.
    Fattah, D.
    Howard, J.
    Lopez, A.
    VALUE IN HEALTH, 2023, 26 (12) : S104 - S105
  • [33] MODEL-PROJECTED LONG-TERM CLINICAL OUTCOMES OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) GENEEDITED THERAPY IN PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN THE UNITED KINGDOM
    Lopez, A.
    Jeyakumar, S.
    Xie, Y.
    Yang, H.
    Li, N.
    Fattah, D.
    Howard, J.
    Wang, J.
    Udeze, C.
    VALUE IN HEALTH, 2023, 26 (12) : S104 - S104
  • [34] Personalizing rare disease research: how genomics is revolutionizing the diagnosis and treatment of rare disease
    Dolled-Filhart, Marisa P.
    Lordemann, Amanda
    Dahl, William
    Haraksingh, Rajini Rani
    Ou-Yang, Chih-Wen
    Lin, Jimmy Cheng-Ho
    PERSONALIZED MEDICINE, 2012, 9 (08) : 805 - 819
  • [35] Revolutionizing gastroesophageal reflux disease diagnosis and treatment: Promise of EPSIS and EARTh
    Shiwaku, Hironari
    DIGESTIVE ENDOSCOPY, 2025,
  • [36] Untapped potential of azathioprine in severe cases of Graves' disease: revolutionizing treatment
    Ali, Tooba
    Mansour, Heba Khaled
    Alsharabi, Tasami Saeed Khaled Ali
    Ali, Muneeba
    Fakih, Nour
    INTERNATIONAL JOURNAL OF SURGERY OPEN, 2024, 62 (04) : 428 - 430
  • [37] Is there treatment for "genetic" disease?
    Scriver, CR
    Treacy, EP
    MOLECULAR GENETICS AND METABOLISM, 1999, 68 (02) : 93 - 102
  • [38] Revolutionizing viral disease treatment: PROTACs therapy could be the ultimate weapon of the future
    Mukerjee, Nobendu
    Ghosh, Arabinda
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (08)
  • [39] Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease
    Gaetano Gallo
    Maurizio Ronconi
    Mario Trompetto
    Updates in Surgery, 2021, 73 : 2029 - 2030
  • [40] Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease
    Gallo, Gaetano
    Ronconi, Maurizio
    Trompetto, Mario
    UPDATES IN SURGERY, 2021, 73 (05) : 2029 - 2030
12345